An alternative set of principles for consideration

Clinicians should treat these data with caution because funding source is strongly associated with reported outcome in published trials. 4 3) It is difficult to assess how others' conflicts of interest might affect their account of the evidence base. 5 Neuman J, Korenstein D, Ross JS, Keyhani S...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) 2012-04, Vol.344 (7854), p.26-26
Main Authors: Yates, Tom A, Reynolds, Carl J
Format: Article
Language:English
Subjects:
Collaboration
COLLABORATION WITH DRUG INDUSTRY
Conflict of Interest
Conflicts of interest
Drug Industry - ethics
England
Health care industry
Health education
Humans
Pharmaceutical industry
Pharmaceutical preparations
R&D
Research & development
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clinicians should treat these data with caution because funding source is strongly associated with reported outcome in published trials. 4 3) It is difficult to assess how others' conflicts of interest might affect their account of the evidence base. 5 Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.
ISSN:0959-8138
1756-1833
1756-1833
DOI:10.1136/bmj.e2927